CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Clinical trial NCT05333874 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05333874
Sponsor: Rutgers, The State University of New Jersey
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer, Early-Onset

Start date: 2022-04-06
Primary completion: 2027-11-28
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.